Titre:
  • Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk.
Auteur:Sherman, Stuart; Cheng, Chi-Liang; Costamagna, Guido; Binmoeller, Kenneth F; Puespoek, Andreas; Aithal, Guruprasad P; Kozarek, Richard; Chen, Yang; Van Steenbergen, Werner; Tenner, Scott; Freeman, Martin; Monroe, Paul; Geffner, Michael; Devière, Jacques; Interleukin-10 ERCP Study Group,
Informations sur la publication:Pancreas, 38, 3, page (267-274)
Statut de publication:Publié, 2009-04
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Interleukin-10
Post-ERCP pancreatitis
MeSH keywords:Acute Disease
Adult
Aged
Cholangiopancreatography, Endoscopic Retrograde -- adverse effects
Cholangiopancreatography, Endoscopic Retrograde -- statistics & numerical data
Female
Humans
Incidence
Injections, Intravenous
Interleukin-10 -- administration & dosage
Interleukin-10 -- adverse effects
Male
Middle Aged
Pancreatitis -- epidemiology
Pancreatitis -- etiology
Pancreatitis -- prevention & control
Placebos
Recombinant Proteins -- administration & dosage
Recombinant Proteins -- adverse effects
Risk Factors
Treatment Failure
Note générale:Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0885-3177
info:doi/10.1097/MPA.0b013e31819777d5
info:pii/00006676-200904000-00005
info:scp/65549121589
info:pmid/19214137